Ocular Therapeutix Announces FDA Approval of Dextenza (dexamethasone intracanalicular insert) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

Print this page BEDFORD, Mass.–(BUSINESS WIRE)–Jun. 21, 2019– Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include the treatment… Read More »

9,125 cups of coffee a year still good for you?

June 6, 2019 Posted By Categories Gary Schwitzer is the founder and publisher of HealthNewsReview.org.  He tweets as @garyschwitzer, or as @HealthNewsRevu. As crazy as our headline sounds, it is merely taking CNN’s headline, below, and spreading it out over a year. CNN quoted one of the researchers: The main message for people to take… Read More »